GUAIFENESIN\PSEUDOEPHEDRINE: 914 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
914
Total FAERS Reports
14 (1.5%)
Deaths Reported
15
Hospitalizations
914
As Primary/Secondary Suspect
2
Life-Threatening
3
Disabilities
Active Ingredient: GUAIFENESIN\PSEUDOEPHEDRINE HYDROCHLORIDE ·
First Report: 19950101 · Latest Report: 20250331
What Are the Most Common GUAIFENESIN\PSEUDOEPHEDRINE Side Effects?
#1 Most Reported
Drug ineffective
134 reports (14.7%)
#2 Most Reported
Insomnia
128 reports (14.0%)
#3 Most Reported
Accidental overdose
74 reports (8.1%)
All GUAIFENESIN\PSEUDOEPHEDRINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 134 | 14.7% | 0 | 1 |
| Insomnia | 128 | 14.0% | 0 | 2 |
| Accidental overdose | 74 | 8.1% | 0 | 0 |
| Dizziness | 67 | 7.3% | 0 | 2 |
| Overdose | 61 | 6.7% | 1 | 4 |
| Nausea | 45 | 4.9% | 0 | 4 |
| Product use in unapproved indication | 37 | 4.1% | 0 | 1 |
| Headache | 36 | 3.9% | 0 | 0 |
| Incorrect drug administration duration | 34 | 3.7% | 0 | 1 |
| No adverse event | 30 | 3.3% | 0 | 0 |
| Expired product administered | 28 | 3.1% | 0 | 0 |
| Drug hypersensitivity | 27 | 3.0% | 0 | 0 |
| Feeling abnormal | 27 | 3.0% | 0 | 1 |
| Underdose | 26 | 2.8% | 0 | 2 |
| Heart rate increased | 25 | 2.7% | 0 | 4 |
| Incorrect product administration duration | 25 | 2.7% | 0 | 0 |
| Vomiting | 25 | 2.7% | 1 | 1 |
| Wrong technique in product usage process | 25 | 2.7% | 0 | 0 |
| Blood pressure increased | 23 | 2.5% | 0 | 2 |
| Dysuria | 23 | 2.5% | 0 | 0 |
Who Reports GUAIFENESIN\PSEUDOEPHEDRINE Side Effects? Age & Gender Data
Gender: 62.8% female, 37.2% male. Average age: 59.7 years. Most reports from: US. View detailed demographics →
Is GUAIFENESIN\PSEUDOEPHEDRINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 0 | 0 |
| 2013 | 4 | 2 | 1 |
| 2014 | 14 | 0 | 1 |
| 2015 | 44 | 0 | 0 |
| 2016 | 96 | 0 | 1 |
| 2017 | 125 | 0 | 1 |
| 2018 | 62 | 1 | 0 |
| 2019 | 63 | 0 | 3 |
| 2020 | 34 | 0 | 0 |
| 2021 | 9 | 0 | 0 |
| 2022 | 39 | 0 | 0 |
| 2023 | 26 | 0 | 1 |
| 2024 | 27 | 0 | 0 |
| 2025 | 14 | 0 | 0 |
What Is GUAIFENESIN\PSEUDOEPHEDRINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 494 |
| Nasal congestion | 76 |
| Cough | 65 |
| Respiratory tract congestion | 58 |
| Nasopharyngitis | 52 |
| Sinus congestion | 28 |
| Productive cough | 27 |
| Sinusitis | 21 |
| Rhinorrhoea | 17 |
| Hypersensitivity | 15 |
GUAIFENESIN\PSEUDOEPHEDRINE vs Alternatives: Which Is Safer?
GUAIFENESIN\PSEUDOEPHEDRINE vs GUANFACINE
GUAIFENESIN\PSEUDOEPHEDRINE vs GUSELKUMAB
GUAIFENESIN\PSEUDOEPHEDRINE vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX
GUAIFENESIN\PSEUDOEPHEDRINE vs HALDOL
GUAIFENESIN\PSEUDOEPHEDRINE vs HALOBETASOL
GUAIFENESIN\PSEUDOEPHEDRINE vs HALOPERIDOL
GUAIFENESIN\PSEUDOEPHEDRINE vs HALOPERIDOL DECANOATE
GUAIFENESIN\PSEUDOEPHEDRINE vs HECTOROL
GUAIFENESIN\PSEUDOEPHEDRINE vs HEMIN
GUAIFENESIN\PSEUDOEPHEDRINE vs HEPARIN
Official FDA Label for GUAIFENESIN\PSEUDOEPHEDRINE
Official prescribing information from the FDA-approved drug label.